[1] TU W J, WANG L D, YAN F, et al. China stroke surveillance report 2021[J]. Military Med Res, 2023, 10: 33. DOI: 10.1186/s40779-023-00463-x. [2] WANG Y J, LI Z X, GU H Q, et al. China stroke statistics: an update on the 2019 report from the national center for healthcare quality management in neurological diseases, China national clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations[J]. Stroke Vasc Neurol, 2022, 7(5): 415-450. DOI: 10.1136/svn-2021-001374. [3] 卢丹丹,王佩,李蒙蒙,等.核磁负担评分与轻型脑卒中早期神经功能恶化的相关性[J].医学研究与教育, 2023, 40(4): 19-24. DOI: 10.3969/j.issn.1674 490X.2023.04.003. [4] 陈子墨,谷鸿秋,李子孝,等.AIS中低密度脂蛋白胆固醇的最佳水平:重新思考 “越低越好”[J].科学通报, 2024, 69(34): 4949-4951. DOI: 10.1360/TB-2024-0882. [5] 苏雪.缺血性脑卒中患者血清UA、Hcy、ApoB/ApoA Ⅰ水平与疾病发生及神经功能缺损程度评分的关系[J].卒中与神经疾病, 2019, 26(2): 214-216, 226. DOI: 10.3969/j.issn.1007-0478.2019.02.020. [6] DONG H L, CHEN W, WANG X Y, et al. Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study[J]. Metab Brain Dis, 2015, 30(6): 1319-1330. DOI: 10.1007/s11011-015-9732-7. [7] LIN J, SI Z H, WANG A H. Predictive value of ApoB/ApoA Ⅰ for recurrence within 1 year after first incident stroke[J]. Front Neurol, 2024, 14: 1308442. DOI: 10.3389/fneur.2023.1308442. [8] TIAN Y F, ZHOU Y P, ZHONG C K, et al. C-reactive protein level, apolipoprotein B-to-apolipoprotein A-1 ratio, and risks of ischemic stroke and coronary heart disease among Inner Mongolians in China[J]. Biomed Environ Sci, 2016, 29(7): 467-474. DOI: 10.3967/bes2016.062. [9] 徐建可,刘宁,韩苗,等.缺血性脑卒中患者颈动脉斑块性质与非高密度脂蛋白胆固醇浓度的相关性[J].首都医科大学学报, 2023, 44(1): 49-53. DOI: 10.3969/j.issn.1006-7795.2023.01.008. [10] WANG G Y, JING J, WANG A X, et al. Non-high-density lipoprotein cholesterol predicts adverse outcomes in acute ischemic stroke[J]. Stroke, 2021, 52(6): 2035-2042. DOI: 10.1161/STROKEAHA.120.030783. [11] JOHANNESEN C D L, MORTENSEN M B, LANGSTED A, et al. ApoB and non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk[J]. Ann Neurol, 2022, 92(3): 379-389. DOI: 10.1002/ana.26425. [12] 罗云.非传统血脂参数与缺血性脑卒中发生及预后的相关性研究[D].长春:吉林大学, 2020: 69-84. [13] WANG Y N, SONG Q H, CHENG Y J, et al. Association between non-high-density lipoprotein cholesterol and haemorrhagic transformation in patients with acute ischaemic stroke[J]. BMC Neurol, 2020, 20(1): 47. DOI: 10.1186/s12883-020-1615-9. [14] LIU Z Z, LIN X M, ZENG L X, et al. Elevated non-HDL-C/HDL-C ratio increases the 1-year risk of recurrent stroke in older patients with non-disabling ischemic cerebrovascular events: results from the Xi’an Stroke Registry Study of China[J]. BMC Geriatr, 2023, 23(1): 410. DOI: 10.1186/s12877-023-04102-x. [15] TIAN Y N, LU L, ZHANG Y Z, et al. The value of Lp(a)and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke[J]. Brain Behav, 2024, 14(1): e3355. DOI: 10.1002/brb3.3355. [16] 宋天娇,高倩,卢丹丹,等.血清脂蛋白(a)及脂肪因子瘦素在急性脑梗死中的诊断价值[J].医学研究与教育, 2021, 38(1):32-36. DOI: 10.3969/j.issn.1674-490X.2021.01.005. [17] ZHANG Y Y, JIA R R, WANG H, et al. Association between lipoprotein(a)and ischemic stroke: fibrinogen as a mediator[J]. J Neurol Sci, 2023, 452: 120738. DOI: 10.1016/j.jns.2023.120738. [18] XU J, HAO X W, ZHAN R, et al. Effect of lipoprotein(a)on stroke recurrence attenuates at low LDL-C(low-density lipoprotein)and inflammation levels[J]. Stroke, 2022, 53(8): 2504-2511. DOI: 10.1161/STROKEAHA.121.034924. [19] ARORA P, KALRA R, CALLAS P W, et al. Lipoprotein(a)and risk of ischemic stroke in the REGARDS study[J]. Arterioscler Thromb Vasc Biol, 2019, 39(4): 810-818. DOI: 10.1161/ATVBAHA.118.311857. [20] QIAN S F, YOU S J, SUN Y M, et al. Remnant cholesterol and common carotid artery intima-media thickness in patients with ischemic stroke[J]. Circ Cardiovasc Imaging, 2021, 14(4): e010953. DOI: 10.1161/CIRCIMAGING.120.010953. [21] WU Z Y, JIANG Y, GUO Z, et al. Remnant cholesterol traits and risk of stroke: a multivariable Mendelian randomization study[J]. PNAS Nexus, 2024, 3(2): pgae033. DOI: 10.1093/pnasnexus/pgae033. [22] XIONG C C, GAO F, ZHANG J H, et al. Investigating the impact of remnant cholesterol on new-onset stroke across diverse inflammation levels: insights from the China Health and Retirement Longitudinal Study(CHARLS)[J]. Int J Cardiol, 2024, 405: 131946. DOI: 10.1016/j.ijcard.2024.131946. [23] TAN Z, ZHANG Q Y, LIU Q W, et al. Relationship between remnant cholesterol and short-term prognosis in acute ischemic stroke patients[J]. Brain Behav, 2024, 14(5): e3537. DOI: 10.1002/brb3.3537. [24] CHE B Z, ZHONG C K, ZHANG R J, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data[J]. Cardiovasc Diabetol, 2023, 22(1): 34. DOI: 10.1186/s12933-023-01762-2. [25] PARK J H, LEE J, OVBIAGELE B. Nontraditional serum lipid variables and recurrent stroke risk[J]. Stroke, 2014, 45(11): 3269-3274. DOI: 10.1161/STROKEAHA.114.006827. [26] LIN J, DONG L B, HUANG Q, et al. TG/HDL-C ratio as a predictor of progressive infarction in patients with anterior circulation single subcortical infarction[J]. Brain Behav, 2024, 14(2): e3453. DOI: 10.1002/brb3.3453. [27] ZHANG S K, CAO C C, HAN Y, et al. A nonlinear relationship between the triglycerides to high-density lipoprotein cholesterol ratio and stroke risk: an analysis based on data from the China Health and Retirement Longitudinal Study[J]. Diabetol Metab Syndr, 2024, 16(1): 96. DOI: 10.1186/s13098-024-01339-3. [28] ZHENG J, SUN Z Q, ZHANG X G, et al. Non-traditional lipid profiles associated with ischemic stroke not hemorrhagic stroke in hypertensive patients: results from an 8.4 years follow-up study[J]. Lipids Health Dis, 2019, 18(1): 9. DOI: 10.1186/s12944-019-0958-y. [29] 张志月,李晶晶,王素洁,等.三种指标与老年缺血性脑卒中颈动脉狭窄患者预后的关系[J].中华老年心脑血管病杂志, 2025, 27(5): 627-631. DOI: 10.3969/j.issn.1009-0126.2025.05.018. [30] KIM H, KIM J T, LEE J S, et al. Impact of non-traditional lipid profiles on 1-year vascular outcomes in ischemic stroke patients with prior statin therapy and LDL-C<100 mg/dL[J]. Sci Rep, 2024, 14(1): 22794. DOI: 10.1038/s41598-024-73851-5. [31] LIU Y T, JIN X L, FU K L, et al. Non-traditional lipid profiles and the risk of stroke: a systematic review and meta-analysis[J]. Nutr Metab Cardiovasc Dis, 2023, 33(4): 698-714. DOI: 10.1016/j.numecd.2023.01.003. [32] XIAO B H, CAO C C, HAN Y, et al. A non-linear connection between the total cholesterol to high-density lipoprotein cholesterol ratio and stroke risk: a retrospective cohort study from the China Health and Retirement Longitudinal Study[J]. Eur J Med Res, 2024, 29(1): 175. DOI: 10.1186/s40001-024-01769-9. [33] LIU X J, YAN L, XUE F Z. The associations of lipids and lipid ratios with stroke: a prospective cohort study[J]. J Clin Hypertens, 2019, 21(1): 127-135. DOI: 10.1111/jch.13441. |